Enhancement of therapeutic efficacy of aclarubicin against lymph node metastases using a new dosage form: aclarubicin adsorbed on activated carbon particles.

C Sakakura; T Takahashi; K Sawai; A Hagiwara; M Ito; S Shobayashi; S Sasaki; K Ozaki; M Shirasu

doi:10.1097/00001813-199206000-00005

Enhancement of therapeutic efficacy of aclarubicin against lymph node metastases using a new dosage form: aclarubicin adsorbed on activated carbon particles.

Identifier:nobleid.org/w1/20260515/B89E2AC1

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/B89E2AC1.svg?ark=w1%2F20260515%2FB89E2AC1)](https://nobleid.org/work/w1/20260515/B89E2AC1)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Enhancement of therapeutic efficacy of aclarubicin against lymph node metastases using a new dosage form: aclarubicin adsorbed on activated carbon particles.

Identifier:nobleid.org/w1/20260515/B89E2AC1

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/B89E2AC1.svg?ark=w1%2F20260515%2FB89E2AC1)](https://nobleid.org/work/w1/20260515/B89E2AC1)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work